EPI-321 – Talk Bio

Actionable Insights Powered by AI

Epicrispr raises $68M, will start clinical trial of epigenetic editing for FSHD

4 weeks ago talkbio0Tagged Clinical Trials, EPI-321, Epicrispr, Muscular Dystrophy, Facioscapulohumeral

Muscular Dystrophy, Facioscapulohumeral, Epicrispr, Clinical Trials, EPI-321